ABVC BioPharma Provides Vitargus® Update
FREMONT, CA, Aug. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical...
Day: August 26, 2021
Nass Valley Creates CBD and Vape Store Value Pack for Wholesale Associates
Vancouver, BC, Aug. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nass Valley Gateway (CSE: NVG.CN) announces the launch of its organic...
Coloplast A/S – Announcement no. 05/2021 – Financial Calendar 2021-22
Please see enclosed pdf. For more information and calendar invitations for upcoming events, please visit: https://investor.coloplast.com/investor-relations/financial-calendar-and-events/. Kind regards,Investor RelationsColoplast A/STel. +45...
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2021 Virtual Healthcare Conference
MINNEAPOLIS, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on...
Shockwave Medical to Participate in Two Upcoming Virtual Investor Conferences
SANTA CLARA, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of...
GoodRx to Present Virtually at Upcoming Investor Conferences
SANTA MONICA, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- GoodRx Holdings Inc. (Nasdaq: GDRX), America’s leading resource for healthcare savings,...
Nuvectis Pharma Raises $15 Million and In-Licenses Exclusive Worldwide Rights to Novel Selective HSF1 Pathway Inhibitor from the CRT Pioneer Fund
NXP800 is a novel, oral, small molecule heat shock factor 1 (HSF1) pathway inhibitor discovered at the Institute for Cancer...
Heat Biologics Unveils Skunkworx Bio, New Drug Discovery Subsidiary
Developing a new era of precision medicines using a unique and proprietary drug discovery platformDURHAM, N.C., Aug. 26, 2021 (GLOBE NEWSWIRE)...
Pardes Biosciences Initiates First-in-Human Trial for PBI-0451, an Oral Antiviral in Development to Treat and Prevent SARS-CoV-2 Infections
CARLSBAD, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Pardes Biosciences, Inc., a clinical-stage biopharmaceutical company today announced the initiation of...
President and CEO of Rafael Pharmaceuticals, Sanjeev Luther, to Present at the 11th Annual World Orphan Drug Congress USA 2021
CRANBURY, N.J., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing...
Excision Announces NIH Martin Delaney Grant Awarded to Temple University to Support “CRISPR for Cure” for HIV
CRISPR-based therapies as a curative approach to HIV infection included in the program for first time.Collaboration with Temple University includes...
Mindset Pharma Announces Preclinical Results Demonstrating Extended Duration of Action in its Long-Acting Next Generation Psychedelic Compounds
TORONTO, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"),...
Alignment Healthcare Launches PPO Plan with Scripps Health in San Diego County
ORANGE, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Medicare Advantage company Alignment Healthcare (NASDAQ: ALHC) today announced the addition of...
Zogenix Receives Orphan Drug Designation for FINTEPLA® (Fenfluramine) in Japan
Zogenix plans to submit a new drug application (J-NDA) for FINTEPLA in Japan for the treatment of seizures associated with...
One Medical Ranked Top Performing HIV Care Provider in New York City
New York City Health Department’s HIV Care Continuum ranks One Medical as the leading provider with 100% complete viral load...
Adagene Reports Financial Results for the Six Months Ended June 30, 2021 and Provides Corporate Updates
- Established three clinical collaborations with Merck to conduct global combination trials with pembrolizumab for three clinical-stage oncology candidates - -...
Vivos Therapeutics and Empower Sleep Launch Cooperative Relationship Aimed at Significantly Improving Proper Obstructive Sleep Apnea Diagnosis and Treatment
HIGHLANDS RANCH, Colo., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical...
Avalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc.
Name change underscores the Company’s transition to developing innovative targeted therapies in immunology, immuno-oncology, and rare genetic diseasesRobust pipeline of...
Aurora Spine Corporation Announces Second Quarter 2021 Financial Results
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE)...
Jushi Holdings Inc. Completes Previously Announced Acquisition of Licensed Processor in Ohio; Announces Debut of the First in a Series of Cannabis Brands in Ohio
Solidifies Presence in Ohio Market with High-Quality Cultivation and Processing Assets Sèche Fine Grind is Now Available at Partner Dispensaries...
